Jci_page_head_homepage_01 Jci_page_head_homepage_02
Masato Furuhashi, Raquel Fucho, Cem Z. Görgün, Gürol Tuncman, Haiming Cao, Gökhan S. Hotamisligil
Published in Volume 118, Issue 7
J Clin Invest. 2008; 118(7):2640–2650 doi:10.1172/JCI34750
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 3
BMT experiments in FABP-deficient mice.

(A) Experimental design of the BMT studies using WT (Ap2+/+Mal1+/+) and FABP-deficient (Ap2–/–Mal1–/–) mice. The numbers in parentheses indicate the timing (week) of performed items. (B) Description and nomenclature for the groups of BMT mice. (C) Genotyping using DNA samples from blood and tail in BMT mice. The graphs on the right show the quantification for the percentages of WT and KO alleles in blood samples. Data are shown as mean ± SEM. (D) Genotyping using DNA samples from white adipose tissue (WAT), liver, and skeletal muscle (soleus) in BMT mice for the donor and recipient alleles. GTT, glucose tolerance test; ITT, insulin tolerance test; Met Cage, metabolic cage study; DEXA, dual energy x-ray absorptiometry; Clamp, hyperinsulinemic-euglycemic clamp study.